Filter the drugs by their status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Latest database update
Number of references
Tocilizumab Recommended by China's NHC Guidelines Used to treat other disease Other treatment Sep/23/2020 Oct/19/2020 0
Monensin Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Jul/06/2020 Sep/07/2020 0
Salinomycin Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Jun/19/2020 Sep/03/2020 0
X-206 Potential treatment - pre-clinical evidence Experimental Antiviral Jun/14/2020 Jun/15/2020 0
Narasin Potential treatment - pre-clinical evidence Experimental Antiviral Jun/14/2020 Jun/15/2020 0
Maduramycin Potential treatment - pre-clinical evidence Experimental Antiviral Jun/14/2020 Jun/15/2020 0
Nanchangamycin Potential treatment - pre-clinical evidence Experimental Antiviral Jun/14/2020 Jun/15/2020 0
Fluoxetine  Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Jun/14/2020 Sep/07/2020 0
EY6A Potential treatment - pre-clinical evidence Experimental Antiviral Jun/13/2020 Jun/15/2020 0
Lenzilumab Potential treatment - clinical evidence Used to treat other disease Other treatment Jun/12/2020 Sep/07/2020 0